FEM
PRAH

Fulcrum Equity Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Fulcrum Equity Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,180
Closed -$936K – 105
2018
Q4 		$936K Buy
+10,180
New +$1.03M 0.34% 6

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fulcrum Equity Management's PRAH Position: Q1 2019 in Review

Fulcrum Equity Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 10,180 shares — an estimated $936K sold.

Fulcrum Equity Management first reported a position in PRAH in Q4 2018 and held it in 1 quarter. The position peaked at $936K in Q4 2018. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • Fulcrum Equity Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • Fulcrum Equity Management sold 10,180 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $936K.
  • Fulcrum Equity Management first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 1 quarter.
  • Fulcrum Equity Management's PRA Health Sciences, Inc. position peaked at $936K in Q4 2018.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Fulcrum Equity Management's 13F filing for Q1 2019, filed 3 May 2019.